Target intelligence / Profile preview

Pathogen adhesins recognizing fucosylated host glycans

Molecular classification
Lectin, Adhesin, Microbial protein
01

Overview

Pathogen adhesins recognizing fucosylated host glycans are microbial surface proteins that mediate the attachment of bacteria and viruses to host epithelial cells by binding to fucose-containing carbohydrate structures (Magalhães et al., 2015, PMID: 26433405). These glycans, including H-type antigens and Lewis antigens (e.g., Lewis b, Lewis x), are widely distributed in the mucus and on the cell surfaces of the gastrointestinal and respiratory tracts. Key examples include the BabA adhesin of Helicobacter pylori, which facilitates gastric colonization, and the LecB lectin of Pseudomonas aeruginosa, which is critical for biofilm architecture and lung infection (Titz, 2017, PMID: 28841286). Noroviruses also utilize these fucosylated histo-blood group antigens (HBGAs) as essential attachment factors for entry into intestinal cells (Ruvoën-Clouet et al., 2013, PMID: 23764352). Because these interactions are the first step in many infections, they are prime targets for anti-adhesion therapies. Such therapies employ glycomimetics or natural human milk oligosaccharides, like 2'-fucosyllactose, to act as decoys that competitively block the adhesin's binding site, thereby preventing pathogen colonization and reducing the risk of disease (Weichert et al., 2016, PMID: 27161353).

Other names
Fucose-binding lectinsFucose-specific microbial adhesinsHisto-blood group antigen (HBGA)-binding adhesinsFucose-recognizing binding proteins
02

Mechanism of action

Competitive inhibition of pathogen attachment to host cell surface glycans by acting as decoy ligands or high-affinity blockers of the adhesin binding site (Weichert et al., 2016, PMID: 27161353).

03

Biological functions

Cell adhesionPathogen colonizationHost-pathogen interactionBiofilm formation
04

Disease associations

InfectionGastritisPeptic ulcer diseaseCystic fibrosis-associated lung infectionGastroenteritis
05

Safety considerations

Potential cross-reactivity with human fucose-binding proteins such as selectins (Magnani, 2004, PMID: 15561015)Potential impact on commensal microbiota that utilize similar glycans (Pickard & Chervonsky, 2015, PMID: 25624130)Low oral bioavailability of carbohydrate-based inhibitors
06

Interacting drugs

2'-Fucosyllactose

4 more in the full profile.

07

Biomarkers

FUT2 genotype (Secretor status)Lewis antigen expression profileFucosylated glycan levels in mucus

Beyond the preview

Go deeper on Pathogen adhesins recognizing fucosylated host glycans.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen adhesins recognizing fucosylated host glycans.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call